Physician profile
Philip Ramirez
NPI 1992143549
$3,972.61
in general payments reported to CMS, 2019-2025
45 companies · $489 in 2025
The $489 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $541 · 2020: $570 · 2021: $365 · 2022: $453 · 2023: $780 · 2024: $773 · 2025: $489.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,043.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,042.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $623.09 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $490.03 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Lilly USA, LLC | $478.23 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Bayer Healthcare Pharmaceuticals INC. | $229.12 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $225.51 | 2019-2025 | Jardiance |
| Misonix INC | $193.69 | 2020-2021 | |
| Glaxosmithkline, LLC. | $188.09 | 2019-2025 | Shingrix, Arexvy, Bexsero |
| Abbvie INC. | $162.35 | 2019-2024 | |
| Pfizer INC. | $150.04 | 2019-2024 | |
| Dexcom, INC. | $134.59 | 2022-2023 | Dexcom G6 Transmitter |
| Abbott Laboratories | $113.08 | 2019-2023 | Freestyle Libre, Freestyle Libre 3 |
| Merck Sharp & Dohme LLC | $86.80 | 2019-2020 | |
| Exact Sciences Corporation | $73.89 | 2023-2024 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $62.81 | 2019-2023 | Xarelto |
| Astellas Pharma US INC | $55.63 | 2020-2025 | Veozah |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Ramirez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.